Cargando…

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus

AIM: To evaluate the relationship between thyroid-stimulating hormone (TSH) levels within the normal range and the risk of type 2 diabetes mellitus (T2DM) in a cohort of patients at high cardiovascular risk, and to perform a systematic review and meta-analysis of previous studies. METHODS: We includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, T. I., Kappelle, L. J., van der Graaf, Y., de Valk, H. W., de Borst, G. J., Nathoe, H. M., Visseren, F. L. J., Westerink, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420678/ https://www.ncbi.nlm.nih.gov/pubmed/30259116 http://dx.doi.org/10.1007/s00592-018-1231-y

Ejemplares similares

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: de Vries, Marieke, et al.
Publicado: (2020)

Lifestyle changes and kidney function: A 10‐year follow‐up study in patients with manifest cardiovascular disease
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making
por: de Vries, Tamar I., et al.
Publicado: (2021)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Thyroid Stimulating Hormone Reference Range: Iranian Thyroid Cohort study
por: Meamar, Rokhsareh, et al.
Publicado: (2021)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Reference ranges for TSH and thyroid hormones
por: Lewandowski, Krzysztof
Publicado: (2015)

Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells
por: Faber, D R, et al.
Publicado: (2012)

"High normal" thyroid stimulating hormone: does it matter?
por: Chun, Hyunji, et al.
Publicado: (2013)

Normal Fasting Triglyceride Levels and Incident Hypertension in Community‐Dwelling Individuals Without Metabolic Syndrome
por: Szili‐Torok, Tamas, et al.
Publicado: (2023)

Live birth rate after intrauterine insemination is not different between women with lower quartile versus higher quartile normal range thyroid stimulating hormone levels
por: Repelaer van Driel- Delprat, C C, et al.
Publicado: (2019)

A systematic review of the relationship between normal range of serum thyroid-stimulating hormone and bone mineral density in the postmenopausal women
por: Zhu, Xiaoli, et al.
Publicado: (2023)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

MON-587 Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The Epiporto Study
por: Neves, João Sérgio, et al.
Publicado: (2019)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

Upper limit of the normal range for thyrotropin-stimulating hormone is higher with increasing age
por: Jolobe, Oscar MP
Publicado: (2012)

Alteration of Thyroid-Related Hormones within Normal Ranges and Early Functional Outcomes in Patients with Acute Ischemic Stroke
por: Xu, Xiao-yan, et al.
Publicado: (2016)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Perinatal factors associated with neonatal thyroid-stimulating hormone in normal newborns
por: Lee, Seong Yong
Publicado: (2016)

Are Thyroid Autoimmune Diseases Associated with Cardiometabolic Risks in a Population with Normal Thyroid-Stimulating Hormone?
por: Chen, Yi, et al.
Publicado: (2018)

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
por: van 't Klooster, Cilie C., et al.
Publicado: (2020)

Thyroid-Stimulating Hormone Within Normal Range Does Not Affect Bone Turnover in Euthyroid Postmenopausal Women with Osteoporotic Fracture - A Preliminary Report
por: Pater, Agnieszka, et al.
Publicado: (2011)

Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country
por: Castillo, Carmen, et al.
Publicado: (2018)

Thyroid-Stimulating Hormone Reference Ranges in Early Pregnancy: Possible Influence of Iodine Status
por: Kim, Tae Yong
Publicado: (2018)

Upper limit of the normal range for thyrotropin-stimulating hormone is higher with increasing age [Corrigendum]
Publicado: (2013)

Normalized difference vegetation index, temperature and age affect faecal thyroid hormone concentrations in free-ranging African elephants
por: Szott, Isabelle D, et al.
Publicado: (2020)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

Trimester-specific thyroid hormone reference ranges in Sudanese women
por: Elhaj, Enaam T., et al.
Publicado: (2016)

Trimester-specific reference ranges for thyroid hormones in pregnant women
por: Zhang, Daowen, et al.
Publicado: (2019)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock
por: Fahrenkrug, J, et al.
Publicado: (2017)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_clccrh3hdjonbiijrvlt6cc739